[Treatment of anxiety with bromazepam in clinical practice (author's transl)].
In this co-operative study 50 patients of both sexes, aged from 18 to 66 years and suffering from neurotic anxiety with functional symptoms were treated with bromazepam (Lexomil) alone for 28 days. With daily doses averaging 6 to 9 mg, good or excellent results were obtained in 78% of the cases, including 58% of somatic cures. Assessment of the anxiety, carried out on days 0, 14 and 28 with the Pull-Guelfi and Hamilton scales, showed optimal response on the 14 th day of treatment in ambulatory patients. Side-effects mostly consisted of sedation which regressed spontaneously or after dosage was reduced.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology; D001960:Bromazepam / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales
D014151:Anti-Anxiety Agents; D001960:Bromazepam
Le traitement de l'anxiété par le bromazépam en médecine practicienne.